ENTRY       D11026                      Drug
NAME        Pegteograstim (INN)
SEQUENCE    MTPLGPASSL PQSFLLKSLE QVRKIQGDGA ALQEKLCATY KLCHPEELVL LGHSLGIPWA
            PLSSCPSQAL QLAGCLSQLH SGLFLYQGLL QALEGISPEL GPTLDTLQLD VADFATTIWQ
            QMEELGMAPA LQPTQGCAMP AFASAFQRRA GGVLVASHLQ SFLEVSYRVL RHLAQP
            (Disulfide bridge: 37-43, 65-75)
  TYPE      Peptide
CLASS       Immunological agent
             DG01753  Colony stimulating factor
              DG01781  Granulocyte colony stimulating factor (G-CSF)
REMARK      ATC code: L03AA17
EFFICACY    Antineutropenic, Granulocyte colony stimulating factor (G-CSF)
TARGET      CSF3R (GCSFR, CD114) [HSA:1441] [KO:K05061]
  PATHWAY   hsa04060(1441)  Cytokine-cytokine receptor interaction
            hsa04151(1441)  PI3K-Akt signaling pathway
            hsa04630(1441)  JAK-STAT signaling pathway
            hsa04640(1441)  Hematopoietic cell lineage
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L03 IMMUNOSTIMULANTS
               L03A IMMUNOSTIMULANTS
                L03AA Colony stimulating factors
                 L03AA17 Pegteograstim
                  D11026  Pegteograstim (INN)
            Drug groups [BR:br08330]
             Immunological agent
              DG01753  Colony stimulating factor
               DG01781  Granulocyte colony stimulating factor (G-CSF)
                D11026  Pegteograstim
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               CSF and other factor receptors
                CSF3R (GCSFR, CD114)
                 D11026  Pegteograstim (INN)
DBLINKS     CAS: 1329602-23-4
            PubChem: 350078345
///
